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Abstract  
Purpose: To compare the performance of near vision activities using additional portable 
electronic vision enhancement systems (p-EVES), to using optical magnifiers alone, by 
individuals with visual impairment. 
Methods: A total of 100 experienced optical aid users were recruited from low vision clinics 
at Manchester Royal Eye Hospital, Manchester, UK, to a prospective two-arm cross-over 
randomised controlled trial. Reading, performance of near vision activities, and device usage 
were evaluated at baseline; and at the end of each study arm (Intervention A:  existing 
optical aids plus p-EVES; Intervention B: optical aids only) which was after 2 and 4 months.   
Results: A total of 82 participants completed the study. Overall, maximum reading speed for 
high contrast sentences was not statistically significantly different for optical aids and p-
EVES, although the critical print size and threshold print size which could be accessed with 
p-EVES were statistically significantly smaller (p<0.001 in both cases). The optical aids were 
used for a larger number of tasks (p<0.001), and used more frequently (p<0.001). However 
p-EVES were preferred for leisure reading by 70% of participants, and allowed longer 
duration of reading (p<0.001). During the study arm when they had a p-EVES device, 
participants were able to carry out more tasks independently (p<0.001), and reported less 
difficulty with a range of near vision activities (p<0.001).  
Conclusions: The study provides evidence that p-EVES devices can play a useful role in 
supplementing the range of low vision aids used to reduce activity limitation for near vision 
tasks. 
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Introduction 
 
A major difficulty reported by individuals with visual impairment (VI) is their inability to carry 
out simple tasks, especially those involving reading. However, optical low vision aids (LVAs) 
can restore that ability, at least partially. Among the LVA users surveyed by Watson et al1, 
97% of hand and stand magnifiers were used for reading, with other popular uses being 
writing, repairing and cooking. Despite the reported usefulness of optical LVAs, users 
identified problems and limitations with them such as insufficient magnification, difficulty with 
lighting the task, and the awkward positioning required. It is also often necessary for users to 
have more than one device if they wish to carry out different tasks. There is evidence that 
some optical LVAs are never used2, which may be related to the limitations of these devices, 
and it may be that some optical LVAs are not used to their full potential.    
In the UK, National Health Service (NHS) low vision clinicians, typically based in hospital 
ophthalmology departments, provide assessment of individuals with VI and dispense optical 
LVAs, such as hand or stand magnifiers, free of charge on permanent loan to help support 
those with sight loss. Moderately priced portable (hand held) electronic vision enhancement 
systems (p-EVES) have recently become available, which offer potential benefits in 
comparison to optical LVAs. For example, p-EVES devices can be used more naturally 
(binocular viewing and habitual working distance) and also incorporate many features not 
seen in optical LVAs (e.g. variable magnification, different contrast settings and freeze frame 
facility). These p-EVES devices are currently on the market to buy privately, but are not 
provided through the NHS in England. In Wales, approximately one third of all optometrists 
are accredited as part of the Low Vision Service Wales and supply optical LVAs within the 
NHS from their community practices.3 For the past few years, it has been possible for them 
to supply one specified p-EVES device, with anecdotal reports from patients and 
practitioners suggesting that these devices are popular and successful. However more 
research was required to evaluate whether this new technology offers real benefits in 
comparison to current optical LVAs, and to establish the exact role that p-EVES devices 
could play within low vision service provision.  
The p-EVES Study was designed to determine the acceptability, effectiveness and cost-
effectiveness of p-EVES devices in addition to existing optical LVAs for near vision activities 
in adults with moderate to severe VI. In this paper we report on acceptability and 
effectiveness: cost-effectiveness is reported elsewhere4  The primary hypotheses 
investigated were that p-EVES devices would (i) allow faster reading, and (ii) be preferred 
(used more often) than a single optical LVA. In addition, a broad range of secondary 
outcome measures were included to explore near vision performance in more detail, and 
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investigate how p-EVES devices affected the user-reported difficulty in carrying out near 
vision activities. 
Methods  
Participants  
 
The p-EVES Study was a single-site study conducted at Manchester Royal Eye Hospital 
(MREH), UK. Inclusion criteria for the study were adults (over 18 years), currently using 
optical LVAs only (not used p-EVES before), stable VI, and visual acuity (VA) of 0.7 logMAR 
(6/30) or worse and/or log contrast sensitivity (CS) of 1.20 or worse (in the better eye). 
Additional criteria were adequate hearing, and English being the habitual language, to meet 
the study demands. Exclusion criteria were a physical disability that prevented the 
participant operating the p-EVES device, or a score of <19 on the Mini-Mental State 
Examination (MMSE-Blind).5 Potential p-EVES trial participants were screened by 
optometrists in the low vision clinics at MREH. Those individuals meeting the 
inclusion/exclusion criteria were given information about the study and then contacted by the 
trial’s clinician researcher.  
 
Trial Design 
 
The study design and methodology have been presented and discussed in a previous 
publication6 and are summarised briefly here. Experienced optical LVA users were recruited 
to a prospective two-arm cross-over randomised controlled trial (RCT). All participants 
underwent an initial p-EVES assessment with the clinician researcher. This assessment 
determined eligibility and informed consent. Participants were subsequently randomised to 
the two arms of the study (Group 1 and Group 2) in a 1:1 ratio. Group 1 received the two 
interventions A and B in the order AB, while Group 2 received the two interventions in the 
order BA. Intervention A was a two month period with both their existing optical LVAs and a 
p-EVES device, and Intervention B was a two month period with their existing optical LVAs 
only. Within each study arm, age (<60, ≥60 years) and visual acuity (VA) (<1.3 LogMAR  
(6/120), ≥1.3 LogMAR (6/120), were binary stratification variables.  
The study researcher was masked to the participants’ Group allocations when the baseline 
assessments (Visit 1) were carried out. Participants were seen by the study researcher three 
times: Visit 1 (baseline) and then at the end of each arm of the study (Visit 2 at 2 months and 
Visit 3 at 4 months).  
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To determine the ways in which individuals incorporated the p-EVES devices into their 
everyday lives, and to obtain their opinions about the different LVAs used during the trial, 
one-to-one semi-structured interviews were conducted after the cross-over study, with a 
sample of participants selected using maximum variation sampling.  
No changes to the protocol were made during the study. The p-EVES Study was registered 
with clinical trials.gov (Identifier: NCT01701700), received National Research Ethics Service 
(NRES) approval and conformed to the tenets of the Declaration of Helsinki. Written 
informed consent was obtained from all participants. 
 
Intervention 
 
 At the initial assessment with the clinician researcher, demographic data were recorded, 
consisting of age, gender, ethnicity, registration status (i.e., not registered, sight impaired 
(SI), severely sight impaired (SSI)), residential status and employment status. Registration 
as SI or SSI is voluntary, and is certified by the ophthalmologist, who takes visual field and 
functional performance into account. However guidelines suggest that the VA for SSI 
registration should be >1.3 logMAR (6/120), and for SI registration should be  ≥1.0 logMAR 
(6/60). Diagnosis was determined (from hospital records of previous clinical examinations), 
and refraction was performed at 3m (based on least-negative prescription with maximum 
achievable VA) followed by measurement of best corrected distance VA (logMAR; ETDRS, 
scored by letter), best corrected near VA at 25cms (point size;  English Continuous Text  
Near Vision Card (Precision Vision, La Salle, IL, USA)), and log CS (using the Pelli-Robson 
chart). The California Central Visual Field Test (CCVFT)7 was used to determine the 
presence of a binocular scotoma, and the location of any preferred retinal locus (PRL). The 
supplier's instructions for CCVFT use were followed, but a grading scale was devised to 
classify the results (for details see Supplementary Information S1). 
The refractive correction and the participant’s optical LVAs were updated and replaced if 
necessary: the participant then had time to incorporate these into everyday routine usage, 
before the baseline assessment. The preferred p-EVES device was selected from the four 
models which were used in the study (Optelec Compact+, Optelec Compact 4HD, Schweizer 
eMAG 43, and Eschenbach Mobilux Digital). These models had been previously chosen by 
a focus group of individuals with VI. These devices are shown in Figure S3 and 
manufacturers' specifications of these devices are provided in Table S2 (see 
Supplementary Information S2). During the initial assessment all participants had the 
opportunity to try all four p-EVES devices and choose the one which best matched their 
requirements, with guidance from the clinician researcher based on an analysis of their 
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needs using Part 1 of the Manchester Low Vision Questionnaire (MLVQ).8 Instruction on the 
operation and basic handling of the selected p-EVES device was given, but no formal 
training was provided (equivalent to the typical situation with NHS hospital provision of 
optical LVAs). To avoid bias, this instruction was also carried out with all optical LVAs. 
Participants attempted five practical tasks with their LVA(s) (p-EVES when in that study arm, 
optical otherwise) to ensure that they were using the devices correctly. Participants 
underwent these task-based practice sessions with the clinician researcher immediately 
following study Visits 1 and 2 (i.e. at the start of each of the 2-month Intervention periods). 
The time taken to carry out the instruction and task-based practice session was recorded for 
each participant.  
The clinician researcher made a scripted telephone call to all participants, 1 week after the 
start of each arm of the study to administer a difficulties questionnaire (whether in Group 1 or 
Group 2). The aim of the questionnaire was to identify difficulties with the LVAs being used 
in that arm of the study. If the device was not working properly, or the participant did not 
know how to operate it, an extra visit was conducted for replacement/re-instruction. 
 
Outcome measures 
 
Outcome measures were assessed at Visit 1 (baseline) and then at the end of each arm of 
the study: Visit 2 (at 2 months) and Visit 3 (at 4 months) by the study researcher (a different 
researcher to that carrying out the initial p-EVES assessment). All measurements taken 
when participants were using either the p-EVES or optical LVAs, were with the device set up 
as chosen by the user. In the case of p-EVES, this set-up may not have been at the optimum 
contrast and/or magnification for the particular task, but this was done to better reflect the 
situation with “real world” usage. All reading performance data were analysed from audio 
recordings.  
 
Three non-visual measures were collected at Visit 1 to investigate whether these tests were 
potentially prognostic for p-EVES success. These were the Brief Resilience Scale9, Finger-
to-Nose Test10, and an adaptation of the Addenbrooke’s Cognitive Examination (ACE-III)11 
(excluding the items which use visual information). These measures determined ability to 
bounce back after set-backs, manual dexterity, and cognitive status, respectively. 
 
Primary outcomes 
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(i) the maximum reading speed (MRS) measured with high contrast (≈90%) MNRead Acuity 
Charts (Minnesota Laboratory for Low-Vision Research, MN, USA), using the p-EVES 
device (at the end of Intervention A – the 2 month period in which the p-EVES was available) 
compared to the preferred optical LVA (at the end of Intervention B – the 2 month period in 
which only optical aids were available),  
and  
(ii) frequency of use (rated on a scale of 0-4) of the p-EVES device during Intervention A 
compared to the optical LVA used most frequently for near vision during Intervention B, 
measured using the MLVQ (Part 2).8  
 
Secondary outcomes relating to near vision activities 
 
In addition to MRS (primary outcome measure), the critical print size (CPS) and threshold 
print size (TPS) were determined using the high contrast MNRead charts and compared 
between p-EVES and preferred optical LVA.12 To investigate whether the contrast 
enhancement features of the p-EVES devices offer a measurable improvement in reading 
performance in reduced contrast conditions, MRS, CPS and TPS were also determined 
using reduced contrast (50%) versions of the MNRead charts. 
The MLVQ was used to determine a number of secondary outcome measures. For those 
participants who at baseline used an optical magnifier to “read books and newspapers”, the 
MLVQ (Part 1) was used to determine whether (i) they subsequently  used a p-EVES for this 
task during Intervention A, and, if so, (from MLVQ Part 2) (ii) what is the longest time they 
could read with the p-EVES device (graded on a scale of 0-4).  It was also used in each 
Intervention to determine which tasks the participant could perform independently with the p-
EVES device (when available), and which with an optical magnifier, and which could not be 
performed, or could only be performed with assistance. 
The International Reading Speed Texts (IReST)13,14 was used to determine reading speed 
and accuracy.15  These parameters were compared for participants who identified preferring 
to use the p-EVES to perform a leisure reading task (“read books and newspapers” (on 
MLVQ Part 1)), and those who preferred to use an optical LVA. 
A set of five timed instrumental activities of daily living (5-TIADLs) were designed to 
determine whether the p-EVES device was spontaneously chosen by the participant to carry 
out a range of everyday tasks, and whether this device allowed faster and/or more accurate 
performance of each task. The five tasks used were: finding a number in a telephone book, 
writing a phrase within a designated space on a piece of paper, reading ingredients on a can 
of food, finding two items from a selection of items on a shelf, and reading information on a 
pill bottle. Speed was assessed as time taken to perform the task (measured on a stop-
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watch to the nearest 0.1 second) and accuracy was assessed using a 5-point grading scale 
(0-4). If the task could not be performed, a grade of 0 was assigned. 
To investigate a wider range of activities than it was practical to test directly, participants 
were asked to rate perceived difficulty during the periods of Intervention A and Intervention B 
respectively, using a 15-item questionnaire (NV-VFQ-15) based on selecting appropriate 
“near vision” items from the VFQ-48 questionnaire.16  
 
Data analysis  
MNRead was used to determine MRS (in words per minute (wpm)), and CPS and TPS (print 
size specified in log point notation).  
MRS was calculated as the mean of the 3 highest reading speeds17 for the sentences read 
with the LVA (participants often began reading the largest print without the LVA, and were 
allowed to choose when to start to use it). Participants’ performances without sufficient data 
points were treated as missing data. CPS was calculated as the smallest print size that 
supports a reading speed equal to 80% of the MRS.17  
The TPS gives a measure of the smallest print size to which the participant’s LVA gives 
them access (also sometimes termed reading acuity). This was calculated as: 
Log print size = 1.9 – (number of sentences read  x 0.1) + (number of errors x 0.01) 
Where: number of errors = number of errors in the last 3 sentences read (approaching TPS). 
 
IBM SPSS (version 20) (https://www.ibm.com/us-en/marketplace/statistical-analysis-and-
reporting) was used to extract data from Excel spreadsheets and create a file of outcome 
measures. R (version 3.0 ) (https://www.r-project.org/) was used to conduct the analyses. 
For the primary and secondary outcome measures two models for the AB/BA crossover 
design were used. The main analysis used was the CROS t test which accounts for 
treatment, period and carry-over effects.18,19 Effect sizes (ES) are presented as an 
unstandardised effect size estimate: positive effect size estimates indicate that the value in 
Intervention A/using a p-EVES is higher than in Intervention B/using an optical aid. 
Conversely negative effect size estimates indicate that the value in Intervention A/using a p-
EVES is lower than that in Intervention B/using an optical aid.During analysis of the 
secondary outcome measures, Bonferroni correction to the p-value to adjust for multiple 
comparisons was used. The NV-VFQ-15 results were used to calculate person visual ability 
scores using previously published algorithms: a spreadsheet provided by the authors was 
used, rather than the formulae given in the published paper.16 
A number of parameters (Group allocation; test order (version sequence); age; distance and 
near VA; CS; CCVFT grade; finger-to-nose test; Brief Resilience Scale and ACE-III scores)  
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were investigated in statistical models for their ability to predict :  the MNRead high contrast 
MRS using p-EVES (a mixed effect linear model); the frequency of use rating (0 to 4) for p-
EVES (a cumulative link model20 ): and the “NV-VFQ-15 score in Intervention A” (a linear 
model). 
 
Results 
 
Recruitment took place between 1st May 2013 and 31st October 2014, with all follow-up visits 
completed by 1st April 2015. The flow of participants through each stage of the study 
(screening, enrolment, randomisation, follow-up and analysis) is shown in Figure 1. A total 
of 780 patients were screened, of whom 247 met the inclusion criteria. Of the 100 patients 
enrolled, 49 were randomised to Group 1 and 51 to Group 2: reasons for non-enrolment of 
147 eligible participants are detailed in Figure 1. The baseline demographic and visual 
characteristics of the participants are summarised for each study arm in Table 1. Overall in 
the study population the mean age was 71.4 years (SD 18.3; range 20 to 93), with 79% 
retired, 62% female, 93% white British. The mean binocular distance VA was 0.96 logMAR 
(6/55) (SD 0.27; range 0.30 to 1.68 (6/12 to 6/287)) and 86% of the participants had a 
certificate of visual impairment (CVI) (with a 50:50 split between those registered as SI and 
SSI).  
A total of 18 participants (18%) dropped out at various points in the trial: 11 from Group 1 
and 7 from Group 2 (Figure 1).  A total of 38 participants in Group 1 and 44 in Group 2 
completed the trial. Participants completing the study had a range of ocular pathologies 
(Table 2) although the majority (61%) had age-related macular degeneration as a primary 
diagnosis. The range of the optical LVAs used by the participants at baseline (and available 
throughout the study) is shown in Table 3. The majority of participants used a hand plus a 
stand magnifier, and 6x was the most common magnification. Table 4 gives details of the p-
EVES used in the study and the length of time spent in each study arm.  
Table 5 shows the reading performance of the participants tested using both the standard 
(high contrast) (Table 5a) and reduced contrast (50%) MNRead test (Table 5b). MRS for 
high contrast sentences was a primary outcome measure, and showed no statistically 
significant difference for p-EVES in comparison to optical LVAs. However, in the assessment 
Visit at the end of Intervention A, 64% of participants chose to use the p-EVES rather than 
their optical aid to perform the MNRead test (those who chose to use their optical aid 
subsequently carried out a second test with the p-EVES).  Considering the MRS for those 
individuals who preferred p-EVES (n=50), there was a small increase with p-EVES relative 
to optical LVAs (p=0.043), whereas there was a non-significant decrease (p=0.079) for 
individuals (n=28) who did not prefer it.  
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A mixed effect linear model was constructed to examine the influence of: Group allocation; 
test order (version sequence); age; distance and near VA; CS; CCVFT grade; finger-to-nose 
test; Brief Resilience Scale and ACE-III scores on the MNRead high contrast MRS using p-
EVES. It was found that the model fitted the data better than the mean (null model) 
(p<0.001). It was not surprising that several visual factors had a statistically significant 
influence: as near VA increases by 1M, MRS decreases by 9.2 wpm (p=0.014), and as log 
CS  increases by 1, MRS increases by 29.4 wpm (p=0.041).  A CCVFT rating other than 0 
(i.e. the presence of any paracentral scotoma), showed a tendency to reduce MRS relative 
to CCVFT grade 0,  although only the decrease for CCVFT grade 2 (46 wpm) reached 
statistical significance (p=0.013).  No demographic or non-visual factors were statistically 
significant.  
The two other parameters derived from the MNRead (CPS and TPS) did however both show 
a highly statistically significant decrease (improvement) when using p-EVES in comparison 
to optical LVAs.  This effect is still apparent (although reduced) for CPS, even for individuals 
who did not prefer p-EVES.  
Considering the reduced contrast MNRead, MRS was statistically significantly worse with p-
EVES than with optical LVAs (p=0.04). In addition, it appears that the MRS for reduced 
compared to high contrast decreases with p-EVES, but stays approximately the same with 
optical LVAs (Table 5). The CPS and TPS are both slightly larger (approximately 0.2 log 
units worse) with reduced contrast, compared to high contrast, in p-EVES, although similar 
for optical LVAs. The p-EVES allows a statistically significant decrease (improvement) in 
CPS overall (p=0.0357). Although there is a tendency for TPS to be improved with p-EVES 
in comparison to optical LVAs, this does not reach statistical significance.  
The second primary outcome measure was frequency of use of p-EVES in comparison to 
the most used optical LVA. Usage was determined with the MLVQ and graded from 0 
(never) to 4 (several times a day). Results show that the most used optical LVA for near 
vision, is used statistically significantly more frequently than the p-EVES (p<0.001) (Table 
6).  A cumulative link model24  was constructed to predict the frequency of use rating (0 to 4) 
for p-EVES using the following factors: Group allocation; test order (version sequence); age; 
distance and near VA; CS; CCVFT grade; finger-to-nose test; Brief Resilience Scale and 
ACE-III scores. The model was statistically significant, χ2 (18) = 30.27, p= 0.035. The only 
statistically significant participant factors were the CCVFT grades. CCVFT grades from 2 to 
4 produced large and statistically significant increases in the rating: by 2.5 for Grade 2 
(p=0.016) and 2.8 for Grade 4 (p=0.010).    
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When only optical LVAs were available (Intervention B), 65% of participants used them for 
leisure reading (reading books and newspapers), but 73% used p-EVES for this task in 
Intervention A (p=1). For spot or survival reading (reading instructions), 84% used optical 
LVAs for this task, whilst only 54% used p-EVES (p=0.012). As survival tasks are likely to be 
more numerous, this finding corroborates the difference in frequency of use; as does the 
statistically significantly higher number of tasks performed with optical LVAs in comparison 
to p-EVES (p=0.002) (Table 6). Although the p-EVES device was not used so frequently, if 
we consider just those participants who performed leisure reading, there was a highly 
statistically significant increase (p<0.001) in the length of time for which p-EVES was used in 
comparison to optical LVAs (Table 6). In the arm of the study when the p-EVES was 
available, participants reported statistically significantly fewer tasks that they could not do or 
with which they needed help (p<0.001). Therefore, whilst the p-EVES does not appear to be 
used for as many tasks, it seems that it can be used for different tasks than optical LVAs; i.e. 
for tasks for which the individual’s existing optical LVAs were not found to be appropriate. 
For example, when only optical LVAs were available, 34% of participants could not or did not 
read books, and 15% could not read instructions: these percentages fell to 11% and 2% 
respectively when p-EVES devices were available.  
The IReST reading test involves longer paragraphs, and so is more representative of a 
leisure reading task. However this test showed no difference in reading speed between the 
preferred optical LVA and p-EVES (Table 6). Table 6 also shows the difference in IReST 
performance for those who were habitually using p-EVES for leisure reading, and those who 
were not. Although the numbers are small, and differences are not statistically significant, 
there appears to be no increase in reading speed relative to optical LVAs for those preferring 
p-EVES, but there is a decrease in reading speed with p-EVES for those who prefer optical 
LVAs. Group 1 shows a large difference in reading speed between the two sub-groups: 
those who preferred optical LVAs had much higher reading speeds than those who preferred 
p-EVES. There was a modest improvement in accuracy with p-EVES compared to optical 
devices for those participants who preferred p-EVES. The proportion of participants 
achieving at least 80% accuracy was 62% with optical LVAs and 70% with p-EVES, although 
this was not statistically significant.   
 
To further explore the use of p-EVES for “survival” reading tasks, Table 7 shows the 
magnifier used for the 5-TIADL tasks. As can be seen, there was a wide variation between 
the tasks in which LVA (if any) the participant chose to use. There was a strong tendency for 
p-EVES preference for Task 1 (telephone directory), and a tendency towards optical LVA 
preference for Task 3 (ingredients), Task 5 (medicine instructions) and (to a lesser extent) 
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Task 4 (items on a shelf). Most participants chose to perform Task 2 (writing) without the use 
of any LVA. Despite these LVA preferences, there were no significant differences in time 
taken, or graded accuracy of performance, on any task when comparing Interventions A and 
B. 
 
The TIADL used only a limited number of practical tasks, but a wider range was explored 
with the NV-VFQ-15. This questionnaire asked participants to rate the difficulty experienced 
for a range of 15 near vision tasks, some of which had also been tested in the TIADL tasks. 
Table 8 shows the Rasch-analysed scores, which indicate a highly statistically significant 
(p<0.001) decrease in the difficulty experienced during the period of  Intervention A when p-
EVES and optical LVAs were available, in comparison to the period of Intervention B with 
optical LVAs alone. A linear model was used to examine the influence of: Group allocation; 
test order (version sequence);  age; distance and near VA; CS; CCVFT grade; finger-to-nose 
test; Brief Resilience Scale and ACE-III scores, on the “NV-VFQ-15 score in Intervention A”. 
This analysis was not a model which had been planned, since NV-VFQ-15 was a secondary 
outcome, but as the NV-VFQ-15 showed a highly statistically significant effect of having p-
EVES available, it was important to investigate whether any of the factors were predictive of 
this success. The model found no statistically significant participant factors to be predictive.  
 
At the end of the study, 34% of participants decided to buy a p-EVES device: 14 participants 
from each Group. 
 
Discussion  
The p-EVES Study is unique in published studies of low vision rehabilitation in combining 
clinical effectiveness, cost effectiveness and qualitative evaluations of an intervention: cost 
effectiveness in particular has rarely been considered.21 Virgili et al22 noted the lack of 
rigorous trials of LVA use, and The p-EVES Study shows how such a trial can be delivered.   
A further strength of The p-EVES Study was the contribution of service users to both the 
study design and conduct. There were also useful interactions with manufacturers of the p-
EVES devices, and the research will provide them with guidance on refining device design.  
The participants recruited covered a wide range of ages, causes of VI, and prescribed 
optical LVAs: 57% used more than one near vision LVA, and 25% also had a distance LVA.  
The vast majority of participants used hand and stand magnifiers (either alone or in 
combination) as has been reported in other UK NHS low vision clinics 23 . Individuals with 
milder levels of VI were excluded from the current study, based on prior clinical experience 
with p-EVES, and the relatively high minimum magnification provided by these devices. The 
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results do not suggest that a poorer VA, or poorer CS, cut-off would be more appropriate 
(i.e. worse than 0.7 logMAR (6/30) or log CS 1.2), since neither VA nor CS were predictive 
factors in the model for p-EVES frequency of use. Based on these clinically-established 
visual criteria, it is likely that there are a significant number of patients in typical low vision 
clinics for whom p-EVES would not be considered. However there are some who would be 
likely to benefit who were not included in this study: some patients had unstable VA, and 
others had already purchased a p-EVES device for themselves. The decision not to restrict 
recruitment to the study on the basis of particular demographic and non-visual 
characteristics (e.g. age, resilience, manual dexterity) was also supported by the study 
results. Analysis showed that none of these characteristics were predictive of performance 
using p-EVES. This finding is important since it has been suggested in the past that, for 
example, younger employed individuals are more likely to be successful EVES users.24,25 
However it must be acknowledged that severe cognitive impairment and physical disability 
were used as exclusion criteria in this study, and these factors would be likely to impinge on 
successful use.  
MRS was chosen as a primary outcome measure because difficulty with reading is a primary 
concern of those with VI, and it is relatively easy to measure using standardised and 
validated tests. In addition, it has been used previously to evaluate the effect of LVAs21,26 , 
and had been shown in earlier studies to be increased with electronic compared to optical 
LVAs.27,28  In the current study, however, there was no statistically significant benefit with p-
EVES for the overall group. There were more drop-outs among the participants than had 
been expected (18% compared to 10%), and some missing data, but there was no indication 
that the lack of significance for MRS was due to an under-powered analysis. In fact some 
participants read faster with optical LVAs than they did with p-EVES.  An improved 
performance with optical LVAs in comparison to head-mounted EVES was reported by 
Culham et al.25 The apparent disagreement in the literature, as to whether electronic or 
optical LVAs allow faster reading, may well be explained by the different characteristics of 
the devices in the different studies. The most obvious difference is that the EVES used in 
some earlier studies had a desk-top screen which therefore has a larger field of view than a 
p-EVES; an advantage over a high-powered optical magnifier would therefore be more likely 
in this case.   
 
When an individual reads with a magnifying device, their CPS and TPS depend on the 
capabilities of the device, and the ability of the user to employ these appropriately, in 
addition to the user’s visual status. It was therefore not surprising that CPS and TPS were 
statistically significantly smaller (“better”) with the p-EVES than with optical LVAs, in view of 
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the higher magnification available (although there is no guarantee that the user will always 
exploit this facility to the full). The question arises whether this statistical improvement has 
functional significance: if it allows the user to access a size of print which they rarely 
encounter in everyday life, then this improvement is not helpful. The improvement in CPS 
(the size of print accessible for leisure reading) was from 8 point with the preferred optical 
LVA to 3.5 point with p-EVES for Group 1, and from 10 point to 6 point for Group 2; the 
change in TPS (the size of print accessible for survival reading) was from 5 point to 2.5 point 
for Group 1 and from 6 point to 4 point for Group 2. These values suggest that although the 
extended magnification range was used by most participants during the test, the functional 
advantage for the majority of everyday activities is likely to be limited. 
Only TPS for users who preferred optical LVAs (i.e. “p-EVES not preferred” in Table 5) did 
not show a statistically significant improvement with the electronic magnifier. This finding 
may have been because these participants were less likely to fully exploit the full 
magnification range of the device, due to less familiarity/expertise with the device.  
One of the unique features of p-EVES in comparison to optical LVAs is the ability to 
change/enhance the contrast of the display. This design feature has the potential to give p-
EVES a significant advantage over optical LVAs when being used to read reduced contrast 
text.  In fact, the results suggest reduced contrast MRS was higher with optical LVAs. There 
are two possible reasons for this finding. Firstly, it may be that the contrast chosen for the 
test (50%) was unrealistically low, and beyond the operating range of the electronic device. 
Culham et al report this phenomenon (described as “saturation” of the display) for low 
contrast targets in the EVES devices they tested.25 Secondly, in order to replicate “real life” 
usage by patients, participants were not guided as to which contrast setting to use for the 
individual tests during the study: they may therefore be making a non-optimal choice.  There 
are several reasons why the set-up may be sub-optimal: users may require training to 
systematically explore the contrast settings, since these are likely to be much less intuitive 
than magnification settings.  In addition, the contrast settings are not particularly user-
friendly: if the user accidentally goes one setting too far in the sequence, they have to scroll 
through them all again, and cannot simply “go back one”.  
The second primary outcome measure was “frequency of use” of the p-EVES device in 
comparison to optical LVAs. The hypothesis was that usage would be increased, since the 
features of the p-EVES device would make it more versatile, and enable use for a wider 
range of tasks.  This hypothesis was not supported by the data, which showed that the most 
used optical LVA was used more frequently than the p-EVES. Further consideration 
suggested that the reason for this finding was that whilst the p-EVES was (slightly) preferred 
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for leisure reading, optical LVAs were significantly preferred for survival reading, and were 
used for a wider range of tasks. Therefore, contrary to expectation, the optical LVA proved to 
be more versatile. Although a p-EVES is less versatile than an optical LVA in the range of 
tasks it permits, the addition of a p-EVES device appears to have allowed a different range 
of tasks to be performed, because there was a reduction in the number of those that could 
either not be undertaken, or required help to perform, when using optical LVAs alone. This 
finding suggests that adding a p-EVES gives the optical aid user the opportunity to be more 
independent, which is likely to improve quality of life, and save on carer time.  
Measuring “duration of use” of a device can be somewhat equivocal. If the task is 
survival/spot reading, short duration is considered positive, since it suggests that the user is 
able to accomplish a task more quickly/efficiently. In contrast, if the task is leisure reading a 
long duration of use is considered beneficial, since it suggests that the experience is 
comfortable and relaxing. Therefore interpretation of the “duration of use” results is 
dependent on the task being performed with the LVA. In the current study “duration of use” 
was compared with p-EVES and optical LVAs, only for those who specifically reported doing 
leisure reading (“reading books/newspapers” on MLVQ). The results showed that p-EVES 
were used for significantly longer periods in this group, suggesting that p-EVES did allow 
more comfortable leisure reading. It might be expected therefore that p-EVES would show 
an advantage over optical LVAs with the IReST test. However, as with MNRead, there was 
no overall improvement in reading speed with p-EVES in comparison to the preferred optical 
LVA.    
In tests of extended reading, such as IReST, it has been argued that accuracy is an 
important parameter as well as speed15, since this is necessary to support comprehension, 
and enable someone to enjoy leisure reading. It therefore follows that any significant 
improvements in accuracy could be a valid reason for LVA preference.  In this study, 80% 
accuracy was chosen as an appropriate minimum requirement. However, improvements in 
accuracy were found to be small, and not sufficient to move statistically significant numbers 
of individuals over the critical 80% boundary. Therefore, whilst 70% of participants chose to 
use p-EVES for leisure reading, it appears that this choice is not based on reading 
performance. It may be related to ergonomic factors such as comfort, posture and being able 
to use both eyes (even if there is no true binocular vision), which may enable individuals to 
use p-EVES for longer durations.  
The results of the 5-TIADL suggest that p-EVES were not perceived by participants to be 
equally useful for each task.  Participants were most likely to choose to use the p-EVES for 
Task 1 (telephone directory: small black and white text on a flat surface), and there was a 
tendency for optical LVAs to be preferred for Tasks 3 (ingredients) and Task 5 (pill bottle). 
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However, use of the p-EVES for Task 1 did not improve accuracy or speed (both of which 
were also poor with optical LVAs). Interestingly, the nature of the inaccuracy in Task 1 was 
very different in the two cases. With optical LVAs, participants found the print too small to 
read, whereas with the p-EVES device they often read a number very easily, but they had 
not accurately navigated the columns and it was the incorrect number. The p-EVES device 
was found to be less popular than optical LVAs for certain tasks despite having specific 
design features that could be seen as advantageous for that task. For example, the 
ingredients on the can were in coloured text (when altering the contrast may have helped); 
or the items on a shelf where the camera would have allowed these to be examined without 
having to pick them up. Manufacturers usually design p-EVES in a way that will allow use for 
writing. However, the results show that very few participants used any sort of magnifier for 
writing. If they did, it was often just to see where to begin (the line they needed to write on), 
or to provide some increased lighting (using the magnifying device as a torch).  
Culham et al found that performance of everyday tasks was slower with EVES in comparison 
to optical LVAs, but there was some question in that study whether it was due to user 
unfamiliarity with the devices.25 In the current study there was no significant difference in 
time or accuracy of performance for any TIADL task using p-EVES compared to optical 
LVAs. Timings in the current study may in fact favour the p-EVES because in the 5-TIADL, 
the p-EVES devices were switched on ready on the table (although not necessarily optimally 
adjusted). Therefore in reality p-EVES devices may be slower, and less preferred, than 
optical LVAs in real everyday usage. The performance of these everyday tasks was often 
slow and inaccurate, regardless of the device used. This outcome is also apparent in the 
MLVQ, in the range of tasks for which participants report needing help from others. There is 
therefore certainly room for improvement in performance of certain IADL and it is not 
surprising that this poor performance would have an effect on quality of life. However, the 
addition of a p-EVES device had a relatively small effect on total functional ability even 
though this difference was highly statistically significant (as measured by the NV-VFQ-15).  
Limitations of this study 
This study has many of the characteristics of a pragmatic rather than explanatory RCT.29 It 
was designed specifically to be able to inform policy decisions on the delivery of 
healthcare,30 and with the aim of being able to translate the findings into clinical prescribing 
guidelines with little delay. Along with its strengths, the pragmatic trial design has some 
disadvantages relative to a narrower explanatory trial, in that the interventions are less rigidly 
specified, though arguably more realistic. Therefore participants already had experience with 
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optical devices, and continued to use these alongside the p-EVES device. They also had 
minimal training, and were allowed to use either device in whatever way they chose: it was 
deliberately not adjusted optimally for them if they had not achieved this themselves. This 
study therefore did not seek to determine the best possible performance with the p-EVES 
(efficacy), but instead the average performance achieved by a representative and 
heterogeneous group of users (effectiveness).31 
The design of the current study inevitably meant that participants were more familiar with 
optical aids than with p-EVES devices. The time allowed to integrate p-EVES within their 
daily routine was only 2 months, but this was based on the fact that previous focus groups 
suggested it only took a few days to become accustomed to p-EVES devices.6 There was 
also no formal training, although participants had 5-30 minutes (mean 15 (SD 6)) of task-
based practice. We feel that this was sufficient since only two participants identified 
difficulties with the p-EVES device when contacted by the clinician researcher after 1 week: 
one was due to a faulty charger (replaced), and the other to difficulty with the on/off switch 
(an additional appointment was conducted for re-instruction). A recent RCT also showed that 
whilst improvements in reading performance32 and in some dimensions of the LVQOL quality 
of life questionnaire33 were found as a result of receiving a CCTV, comprehensive training in 
use of the device did not provide any additional benefit. 
Recruitment was only from a single site, although this site was a typical NHS low vision 
clinic, albeit one based in a large eye hospital. The range of participants was broadly similar 
to that in other reported low vision populations23, 34 suggesting that these results would be 
generalisable to other clinics. The participants in the current study were almost exclusively of 
white British ethnicity. Unfortunately some participants of other ethnicities were excluded 
because English was not their habitual language. That population is likely to be excluded 
from any trial that uses standardised reading tests. 
Participants were able to choose a preferred p-EVES device from a limited range (n=4) 
which had been pre-selected by a (different) group of individuals with VI. Within the context 
of potential future supply of (possibly a single) p-EVES through the NHS, the focus group 
brief was to identify a device which had the potential to be used for all types of reading. This 
selection may have influenced the results of this study: a smaller, simpler device may have 
gained more usage for survival tasks, and a device with a larger screen may have been 
even more popular/successful for leisure reading. It is probable, however, that newer 
designs of p-EVES would give similar results to these models, if the range of features, and 
the overall quality of the devices, is similar.  
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The difficulty in masking in a study of this type means that there is some possibility of bias. 
The study researcher was masked to the group allocation of the participant when the 
baseline assessment was carried out, but not at any subsequent study visits. Obviously the 
participants were also not masked, but this limitation may have caused a bias either way: 
towards the p-EVES as the novel technology; or towards optical LVAs due to the 
participants’ satisfaction and familiarity with them (an inclusion criterion was that they were 
already optical LVA users). It was unavoidable that participants would already be familiar 
with optical LVAs, since electronic devices provide too high a level of magnification to be 
acceptable to those with mild impairment.    
 
Conclusions 
 
This study suggests that p-EVES do not replace optical LVAs, among those who already use 
optical devices, but can serve a useful purpose if prescribed in conjunction with them. A total 
of 34% of participants found the p-EVES so useful that they decided to purchase it at the 
end of the study, despite the fact that they were accustomed to having their LVAs provided 
free of charge by the NHS. The p-EVES devices are most useful for extended reading tasks, 
and may be a helpful addition for participants who find that their optical LVAs are 
unsatisfactory; and/or for users who find there are several tasks they cannot do, or with 
which they need help, when using their optical LVAs. A significant minority of patients being 
seen in NHS Low Vision Clinics could benefit from p-EVES being added to the possible 
devices available for supply. There were no participant factors which were predictive of the 
person’s visual ability whilst using p-EVES, suggesting that these devices are potentially 
useful for a wide range of individuals with moderate/severe VI. The findings of the study are 
sufficient to support a bid to commissioners of services to extend p-EVES supply into NHS 
clinics across the UK. 
The successful combination of user performance, user opinion, and cost-effectiveness used 
in The p-EVES Study, could offer a template for other pragmatic evaluations of rehabilitation 
interventions. Whilst some highly significant benefits to p-EVES users were found in this 
study, these benefits were not universal: some findings were counter-intuitive, and several 
contradicted the original hypotheses of the study. Such outcomes show the importance of 
robust investigation of new technologies, which might (incorrectly) be assumed to always be 
"better". The study illustrates the importance of the use of a range of outcome measures in 
studies of low vision rehabilitation, since the disability, and the intervention, can affect so 
many aspects of life.  
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Figure 1  Details of the participants involved at each stage of the study 
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Table 1: Demographic and visual characteristics of participants recruited to the study.  
 
 
Abbreviations: CVI = Certificate of visual impairment, SSI = severely sight impaired, 
SI = sight impaired, FTE = full-time education, VA = visual acuity, CCVFT = California 
Central Visual Field Test. 
 
 
 
 
 
 
 Group 1 (n=49) Group 2 (n=51) 
Age (years)                                                      mean (SD) 69.8 (20.0) (range 20-93) 72.9 (16.6) (range 34-93) 
Gender Male                                                            n (%) 20 (41) 18 (35) 
Ethnicity                                                                    n (%) 
          White British 
          Other 
 
45 (92) 
4   (8) 
 
48 (94) 
3   (6) 
Registration (CVI) status                                        n (%) 
          SSI 
          SI 
          Not registered 
 
22 (45) 
18 (37) 
9   (18) 
 
21 (41) 
25 (49) 
5   (10) 
Residential status                                                    n (%) 
          Alone 
          With spouse/partner 
          With family/friends 
 
 
19 (39) 
11 (22) 
19 (39) 
 
 
24 (47) 
10 (20) 
17 (33) 
Employment status                                                 n (%) 
          Employed 
          Unemployed 
          Retired 
          FTE 
 
 
4   (8) 
6   (12) 
38 (78) 
1   (2) 
 
 
3   (6) 
7   (14) 
41 (80) 
0   (0) 
Binocular distance VA (LogMAR)              mean (SD) 
                                          (Snellen)                mean 
0.95 (0.30) (range 0.30 to 1.68) 
6/53 (range 6/12 to 6/287) 
0.96 (0.25) (range 0.52 to 1.68) 
6/55 (range 6/20 to 6/287) 
Near VA (point size) at 25cm                   mean (SD) 21.3 (13.4) (range 5-50) 20.2 (10.6) (range 3-50) 
Central visual field status (CCVFT grade)  mean (SD) 2.5 (1.4) (range 0 to 5) 3.1 (1.5) (range 0 to 5) 
(Log) Contrast sensitivity (Pelli Robson)  mean (SD) 0.78 (0.37) (range 0 to 1.5) 0.75 (0.31) (range 0 to 1.35) 
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Table 2 The breakdown of primary ocular pathologies amongst the study participants who 
completed the study (n = 82).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary Diagnosis Group 1 Group 2 
Dry AMD 11 14 
Wet AMD 10 12 
Stargardt disease 2 1 
Retinitis pigmentosa 1 2 
High myopia/myopic 
degeneration 
4 1 
Glaucoma 0 6 
Diabetic retinopathy 2 0 
Nystagmus 4 1 
Other 4 7 
TOTAL 38 44 
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Table 3 The type of optical low vision aids used for near vision activities by participants who 
completed the study (n=82). The number and percentage of participants owning each 
combination of devices are shown.   
 
 
 
Table 4 The details of the devices used in Intervention A and the time spent in each study 
arm, for participants in each group.  . 
 
 
 
 
 
 
 
 Group  1  Group  2  
Hand Magnifier(s) Only                  n (%)           
                     
14 (37) 
 
12 (27) 
 
Stand Magnifier(s) Only                 n (%)  
 
4 (11) 5 (11) 
Hand + Stand Magnifiers               n (%)             
           
14 (37) 
 
24 (55) 
Other                                                n (%) 
 
6 (16) 3 (7) 
  Group 1  Group 2  
p-EVES prescribed Optelec Compact+                           n (%) 1 (3) 3 (7) 
Optelec Compact 4HD                     n (%) 17 (45) 11 (25) 
Schweizer eMAG 43                         n (%) 17 (45) 29 (66) 
Eschenbach Mobilux Digital            n (%) 3 (8) 1 (2) 
Time in task-
based practice 
(minutes) 
                                                           mean (SD) 
                                      
13.7 (5) 15.5 (6) 
Time in each 
study arm (days) 
Intervention A                      median (IQR) 68 (60 to 76)  68 (62 to  85) 
Intervention B                      median (IQR) 61 (56 to 74) 61 (55 to 65) 
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Table 5: The mean (SD) maximum reading speed (MRS), critical print size (CPS), and threshold print size (TPS), as measured using the 
MNRead  high contrast (a)  and MNRead reduced contrast (b)  charts, for each intervention in both groups. ES is unstandardised effect size 
estimate 
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a:  MNRead High Contrast 
 Group 1  
 
Group 2  
 
 
 Using p-EVES 
 
Using optical 
aid 
  
Using p-EVES 
  
Using optical aid 
 
ES, 95% CI, p-value 
 
MRS (words per minute) 86.5 (50.0) 
(n=37) 
77.4 (44.2) 
(n=37) 
64.3 (41.9) 
(n=41) 
65.3 (38.5) 
(n=41) 
ES=4.04; p=0.24 
95% CI [-2.81,10.9] 
t(70.71)=1.18 
MRS (words per minute) 
(p-EVES preferred) 
86.4 (47.9) 
(n=26) 
71.6 (40.7) 
(n=26) 
68.5 (40.2) 
(n=24) 
63.5 (35.0) 
(n=24) 
ES=9.87; p=0.043  
95% CI [0.32 ,19.42]  
t(47.94) =2.08 
MRS (words per minute) 
(p-EVES not preferred) 
86.7 (57.0) 
(n=11) 
91.0 (50.9) 
(n=11) 
58.3 (44.7) 
(n=17) 
67.8 (43.8) 
(n=17) 
ES=-6.89; p=0.079  
95% CI [-14.66,0.89] 
t(19.61) = -1.85 
CPS (log point size) 0.5 (0.3) (n=37) 0.9 (0.2) (n=37) 0.8 (0.3) (n=41) 1.0 (0.3) (n=41) ES=-0.29; p<0.001  
95% CI [-0.35, -0.23] 
t(74.88)= -9.68 
CPS (log point size) 
(p-EVES preferred) 
0.5 (0.2) (n=26) 0.9 (0.3) (n=26) 0.7 (0.3) (n=24) 1.0 (0.2) (n=24) ES=-0.33; p<0.001 
95% CI [-0.41 , -0.25] 
t(47.59)=-8.13 
CPS (log point size) 
(p-EVES not preferred) 
0.6 (0.3) 
(n=11) 
0.9 (0.2) (n=11) 0.8 (0.3) (n=17) 1.0 (0.3) (n=17) ES=-0.24; p=0.003 
95% CI [-0.34, -0.14] 
t(20.49) =-5.14 
TPS (log point size) 0.4 (0.2) (n=37) 0.7 (0.2) (n=37) 0.6 (0.4) (n=41) 0.8 (0.3) (n=41) ES=-0.26; p<0.001  
95% CI [-0.32, -0.2] 
t(75.82)=-8.78 
TPS (log point size) 
(p-EVES preferred) 
0.4 (0.2) (n=26) 0.7 (0.2) (n=26) 0.5 (0.4) (n=24) 0.8 (0.3) (n=24) ES=-0.32; p<0.001  
95% CI [-0.39,-0.25] 
t(46.74) =-9.19 
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TPS (log point size) 
(p-EVES not preferred) 
0.4 (0.3) (n=11) 0.7 (0.2) (n=11) 0.7 (0.4) (n=17) 0.8 (0.3) (n=17) ES=-0.16; p=0.53  
95% CI [-0.26, -0.05] 
t(18.7)=-3.0 
b:  MNRead Reduced Contrast 
 Group 1  
 
Group 2  
 
 
 Using p-EVES Using optical 
aid  
Using p-EVES  Using optical aid ES, 95% CI, p-value 
MRS (words per minute) 75.5 (41.8) 
(n=36) 
81.6 (43.8) 
(n=36) 
49.9 (29.6) 
(n=36)                            
66.9 (39.2) 
(n=36) 
ES=-11.58; p=0.04 
95% CI [-17.96, -5.19] 
t(67.15) = -3.62 
MRS (words per minute) 
(p-EVES preferred) 
74.2 (42.2) 
(n=27) 
78.0 (43.1) 
(n=27) 
52.6 (34.6) 
(n=24) 
66.3 (45.3) 
(n=24) 
ES=-8.78; p=1 
95% CI [-16.61,-0.95] 
t(48.74) = -2.25 
MRS (words per minute) 
(p-EVES not preferred) 
79.5 (42.8) (n=9) 92.4 (46.7) 
(n=9) 
44.3 (15.1) 
(n=12) 
68.0 (23.1) 
(n=12) 
ES=-18.31; p=1 
95% CI [-31.95, -4.63]  
t(10.52)=2.96 
CPS (log point size) 0.8 (0.3) (n=36) 0.9 (0.2) (n=36) 0.9 (0.3) (n=36) 1.0 (0.3) (n=36) ES=-0.11; p=0.0357  
95% CI [-0.17, -0.05] 
t(61.86) = -3.67 
CPS (log point size) 
(p-EVES preferred) 
0.8 (0.2) (n=27) 0.9 (0.2) (n=27) 0.9 (0.3) (n=24) 1.1 (0.3) (n=24) ES=-0.13; p=0.0524  
95% CI [-0.2, -0.06] 
t(37.37) =-3.68 
CPS (log point size) 
(p-EVES not preferred) 
0.8 (0.4)  
(n=9) 
0.9 (0.2) (n=9) 0.9 (0.3) (n=12) 1.0 (0.3) (n=12) ES=-0.07; p=1 
95% CI [-0.2, 0.06] 
t(18.37)=-1.1 
TPS (log point size) 0.6 (0.3) (n=36) 0.7 (0.2) (n=36) 0.7 (0.3) (n=36) 0.8 (0.3) (n=36) ES=-0.1; p=0.08 
95% CI [-0.17, -0.04]  
t(68.03)=-3.4 
TPS (log point size)  
(p-EVES preferred) 
0.6 (0.2) (n=27) 0.8 (0.2) (n=27) 0.8 (0.3) (n=24) 0.8 (0.3) (n=24) ES=-0.11; p=0.26 
95% CI [-0.18,-0.04] 
t(39.46)=-3.09 
TPS (log point size) 0.6 (0.4)  0.7 (0.2) (n=9) 0.7 (0.2) (n=12) 0.8 (0.2) (n=12) ES=-0.09; p=1 
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Table 6   Selected responses (mean (SD)) from the MLVQ (a), and the IReST (b) reading performance, for each Intervention in both groups.   
ES is unstandardised effect size estimate.  
a: MLVQ    
 Group 1  Group 2  ES, 95% CI and p value 
  
Using p-EVES 
 
Using an 
optical aid  
 
Using p-EVES 
 
Using an 
optical aid 
 
 
 
Frequency of use of aid 
(grade 0 to 4) 
2.7 (1.2) 
(n=38) 
3.2 (1.2) 
(n=38) 
2.1 (1.4) 
(n=44) 
3.5 (0.9) 
(n=44) 
ES=-0.93, p<0.001 
95% CI [-0.57, -1.29]  
t(75.69)=-5.19 
 
Number of tasks with aid 
5.7 (3.3) (n=38) 7.0 (2.9) 
(n=38) 
4.0 (3.7) 
(n=44) 
6.9 (3.3) 
(n=44) 
ES=-2.09; p=0.002 
95% CI [-3.03, -1.15] 
t(74.33)=-4.44 
Longest duration of use for 
͞p-EVES leisure readers͟ 
(grade 0 to 4)  
3.0 (1.2) 
(n=29) 
2.0 (1.2) 
(n=29) 
3.1 (1.0) 
(n=29) 
2.5 (1.2) 
(n=29) 
ES= 0.84; p<0.001 
95% CI [0.54, 1.15] 
t(54.03)=5.54 
 Intervention A  Intervention B Intervention A Intervention B  
 
Number of tasks cannot 
do/need help with 
3.3 (3.8) (n=38) 4.7 (3.6) 
(n=38) 
4.8 (3.7) 
(n=44) 
6.6 (4.3) 
(n=44) 
ES=-1.62; p<0.001 
95% CI [-1.03, -2.21] 
t(68.93)=-5.46 
b: IReST 
 (p-EVES not preferred) (n=9) 95% CI [-0.24, 0.06] 
t(14.85)=-1.3 
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 Group 1 Group 2  ES, 95% CI and p value 
 Using p-EVES Using an 
optical aid  
Using p-EVES Using an 
optical aid 
 
Reading 
Speed (words per minute) 
52.7 (32.3) 
(n=37) 
57.1 (45.2) 
(n=37) 
38.1 (31.2) 
(n=44) 
37.1 (39.9) 
(n=44) 
ES=-1.7; p=1 
95% CI [-7.21, 3.81] 
t(74.13)=-0.61 
Reading speed for ͞p-EVES 
leisure readers͟ (words per 
minute) 
47.5 (28.2) 
(n=28) 
49.6 (39.2) 
(n=28) 
41.8 (35.1) 
(n=29) 
40.3 (45.0) 
(n=29) 
ES=-0.24; p=1 
95% CI [-6.88, 6.39] 
t(54.83)= -0.07 
Reading speed for ͞non-p-
EVES leisure readers͟ 
(words per minute) 
85.1 (25.9) (n=6) 109.4 (41.3) 
(n=6) 
33.1 (23.4) 
(n=7) 
39.2 (22.0) 
(n=7) 
ES=-15.21; p=1 
95% CI [-28.04, -2.37] 
t(10.6)=-2.62 
Accuracy (%) 85.6 (22.0)  
(n=37) 
79.1 (30.0) 
(n=37) 
72.9 (33.4) 
(n=44) 
61.8 (40.8) 
(n=44) 
ES=8.79; p=0.679 
95% CI [2.20, 15.38] 
t(79.0)=2.66 
Accuracy for ͞p-EVES 
leisure readers͟ (%) 
86.2 (19.5) 
(n=28) 
78.6 (29.1) 
(n=28) 
78.8 (30.8) 
(n=29) 
64.0 (39.8) 
(n=29) 
ES=11.24; p=0.274 
95% CI [3.77, 18.70] 
t(54.67)=3.02 
Accuracy for ͞non-p-EVES 
leisure readers͟ (%) 
97.2 (6.2)  
(n=6) 
96.4 (8.9) 
(n=6) 
67.9 (46.2) 
(n=7) 
81.0 (35.9) 
(n=7) 
ES=-6.13; p=1 
95% CI [-22.37, 10.10] 
t(6.08)=-0.92 
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Table 7 The number of participants (n (%)) who used each type of LVA in each TIADL task is shown.  *one participant missed Task 2 due to a 
broken arm; # one participant missed Task 4 because equipment not available. 
 Group 1  Group 2   
Intervention A  Intervention B  Intervention A Intervention B    
TIADL  n=38 n=44*#  
Task 1 
Phone 
number 
Mag 
used 
Optical  8 (21) 
p-EVES 30 (79) 
no aid 0 (0) 
Optical 37 (97) 
 
no aid 1 (3) 
Optical 17 (39) 
p-EVES 27 (61) 
no aid 0 (0) 
Optical 44 (100) 
 
no aid 0 (0) 
 
Task 2 
Writing 
Mag 
used 
Optical 3 (8) 
p-EVES 2 (5) 
no aid 33 (87)  
Optical 4 (11) 
 
no aid 34 (89) 
Optical 4 (9) 
p-EVES 2 (5) 
no aid 37 (86) 
Optical 5 (12) 
 
no aid 38 (88) 
 
Task 3 
Can 
ingredients 
Mag 
used 
Optical 21 (55) 
p-EVES 17 (45) 
no aid 0 (0) 
Optical 37 (97) 
 
no aid 1 (3) 
Optical 31 (70) 
p-EVES 13 (30) 
no aid 0 (0) 
Optical 44 (100) 
 
no aid 0 (0) 
 
Task 4 
Shelf 
Mag 
used 
Optical 8 (21) 
p-EVES 8 (21) 
no aid 22 (58) 
Optical 16 (42) 
 
no aid 22 (58) 
Optical 20 (47) 
p-EVES 7 (16) 
no aid 16 (37) 
Optical 23 (53) 
 
no aid 20 (47) 
 
Task 5 
Pill bottle 
Mag 
used 
Optical 19 (50) 
p-EVES 18 (47) 
no aid 1 (3) 
Optical 37 (97) 
 
no aid 1 (3) 
Optical 31 (70) 
p-EVES 13 (30) 
no aid 0 (0) 
Optical 44 (100) 
 
no aid 0 (0) 
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Table 8 The mean (SD) visual ability from Rasch analysis of the responses to the NV-VFQ-15 questionnaire made up of selected “near vision” 
items from the VFQ-48 instrument. ES is unstandardized effect size estimate, CI is confidence interval.   
 
Group 1 Group 2  ES, 95% CI and p value 
Intervention A  Intervention B  Intervention A Intervention B  
2.2 (1.2) (n=38) 1.6 (1.4) (n=38) 1.8 (1.4) (n=44) 1.3 (1.2) (n=44) ES =0.57; p<0.001 
95% CI [0.33, 0.81] 
t(67.3)=4.69 
